PolyPeptide Group - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PolyPeptide Group

PolyPeptide Group is a leading provider of custom/generic peptides for research and pharmaceutical applications with 6 facilities worldwide.  Our focus is on proprietary and generic GMP-grade peptides for the pharmaceutical and biotechnological market.  With more than 50 years of experience, we are committed to the highest quality of peptide manufacturing for every stage of product development.

Company name:  PolyPeptide Group

Website: www.polypeptide.com

E-mail: strasbourg@polypeptide.com
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FindPharma Custom Search

Click here